Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kandimalla, ER; Yu, D; Zhao, QY; Agrawal, S
      Effect of chemical modifications of cytosine and guanine in a CpG-Motif ofoligonucleotides: Structure-immunostimulatory activity relationships

      BIOORGANIC & MEDICINAL CHEMISTRY
    2. Yu, D; Kandimalla, ER; Zhao, QY; Cong, YP; Agrawal, S
      Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosphonate linkages

      BIOORGANIC & MEDICINAL CHEMISTRY
    3. Yu, D; Kandimalla, ER; Zhao, QY; Cong, YP; Agrawal, S
      Modulation of immunostimulatory activity of CpG oligonucleotides by site-specific deletion of nucleobases

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Yu, RZ; Geary, RS; Leeds, JM; Watanabe, T; Moore, M; Fitchett, J; Matson, J; Burckin, T; Templin, MV; Levin, AA
      Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkey

      JOURNAL OF PHARMACEUTICAL SCIENCES
    5. Hiratou, T; Tsukahara, S; Miyano-Kurosaki, W; Takai, K; Saito, T; Yamamoto, N; Takaku, H
      Anti-HIV-1 activity by a triple-helix forming oligonucleotides targeted topolypurine tract on viral RNA

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    6. Hiratou, T; Miyano-Kurosaki, N; Tsukahara, S; Tamura, Y; Takai, K; Yamamoto, N; Takaku, H
      Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    7. Rusckowski, M; Qu, T; Roskey, A; Agrawal, S
      Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose administration in mice

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    8. Ghosh, C; Iversen, PL
      Intracellular delivery strategies for antisense phosphorodiamidate morpholino oligomers

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    9. Khan, A; Sommer, W; Fuxe, K; Akhtar, S
      Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain

      JOURNAL OF DRUG TARGETING
    10. Lee, PA; Blatt, LM; Blanchard, KS; Bouhana, KS; Pavco, PA; Bellon, L; Sandberg, JA
      Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration inmice

      HEPATOLOGY
    11. Lin, SB; Wu, LC; Huang, SL; Hsu, HL; Hsieh, SH; Chi, CW; Au, LC
      In vitro and in vivo suppression of growth of rat liver epithelial tumor cells by antisense oligonucleotide against protein kinase C-alpha

      JOURNAL OF HEPATOLOGY
    12. Arora, V; Iversen, PL
      Antisense oligonucleotides targeted to the p53 gene modulate liver regeneration in vivo

      DRUG METABOLISM AND DISPOSITION
    13. Kairemo, KJA; Jekunen, AP; Tenhunen, M
      Dosimetry and optimization of in vivo targeting with radiolabeled antisense oligodeoxynucleotides: Oligonucleotide radiotherapy

      ANTISENSE TECHNOLOGY, PT B
    14. Shi, NY; Boado, RJ; Pardridge, WM
      Antisense imaging of gene expression in the brain in vivo

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    15. Boado, RJ; Kazantsev, A; Apostol, BL; Thompson, LM; Pardridge, WM
      Antisense-mediated down-regulation of the human huntingtin gene

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    16. Park, WS; Miyano-Kurosaki, N; Abe, T; Takai, K; Yamamoto, N; Takaku, H
      Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNAchimeric oligonucleotides

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    17. Zhou, W; Tomer, KB; Khaledi, MG
      Evaluation of the binding between potential anti-HIV DNA-based drugs and viral envelope glycoprotein gp120 by capillary electrophoresis with laser-induced fluorescence detection

      ANALYTICAL BIOCHEMISTRY
    18. Hogrefe, RI
      An antisense oligonucleotide primer

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    19. Gokhale, PC; McRae, D; Monia, BP; Bagg, A; Rahman, A; Dritschilo, A; Kasid, U
      Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    20. Jiang, ZW; Kandimalla, ER; Zhao, QY; Shen, LX; DeLuca, A; Normano, N; Ruskowski, M; Agrawal, S
      Pseudo-cyclic oligonucleotides: In vitro and in vivo properties

      BIOORGANIC & MEDICINAL CHEMISTRY
    21. Meisler, NT; Chiu, JF; Cutroneo, KR
      Promoter competitors as novel antifibrotics that inhibit transforming growth factor-beta induction of collagen and noncollagen protein synthesis in fibroblasts

      JOURNAL OF CELLULAR BIOCHEMISTRY
    22. Pardridge, WM
      Vector-mediated drug delivery to the brain

      ADVANCED DRUG DELIVERY REVIEWS
    23. Agrawal, S
      Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides

      BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION
    24. Iversen, PL; Cornish, KG; Iversen, LJ; Mata, JE; Bylund, DB
      Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    25. Hiratou, T; Tsukahara, S; Miyano-Kurosaki, N; Takai, K; Yamamoto, N; Takaku, H
      Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted tothe polypurine tract

      FEBS LETTERS
    26. Khaled, Z; Ho, YY; Benimetskaya, L; Deckelbaum, RJ; Stein, CA
      omega-6 polyunsaturated fatty acid-stimulated cellular internalization of phosphorothioate oligodeoxynucleotides - Evidence for protein kinase C-zetadependency

      BIOCHEMICAL PHARMACOLOGY
    27. CROOKE ST
      AN OVERVIEW OF PROGRESS IN ANTISENSE THERAPEUTICS

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    28. AKHTAR S
      ANTISENSE TECHNOLOGY - SELECTION AND DELIVERY OF OPTIMALLY ACTING ANTISENSE OLIGONUCLEOTIDES

      Journal of drug targeting
    29. AGRAWAL S; ZHANG XS; CAI QY; KANDIMALLA ER; MANNING A; JIANG ZW; MARCEL T; ZHANG RW
      EFFECT OF ASPIRIN ON PROTEIN-BINDING AND TISSUE DISPOSITION OF OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS

      Journal of drug targeting
    30. BOADO RJ; TSUKAMOTO H; PARDRIDGE WM
      DRUG-DELIVERY OF ANTISENSE MOLECULES TO THE BRAIN FOR TREATMENT OF ALZHEIMERS-DISEASE AND CEREBRAL AIDS

      Journal of pharmaceutical sciences
    31. BRAND RM; WAHL A; IVERSEN PL
      EFFECTS OF SIZE AND SEQUENCE ON THE IONTOPHORETIC DELIVERY OF OLIGONUCLEOTIDES

      Journal of pharmaceutical sciences
    32. ARORA V; IVERSEN PL; EBADI M
      MANIPULATION OF METALLOTHIONEIN EXPRESSION IN THE REGENERATING RAT-LIVER USING ANTISENSE OLIGONUCLEOTIDES

      Biochemical and biophysical research communications
    33. GROOTHUIS DR; LEVY RM
      THE ENTRY OF ANTIVIRAL AND ANTIRETROVIRAL DRUGS INTO THE CENTRAL-NERVOUS-SYSTEM

      Journal of neurovirology
    34. ALAMA A; BARBIERI F; CAGNOLI M; SCHETTINI G
      ANTISENSE OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS

      Pharmacological research
    35. ANAZODO MI; DUTA E; SALOMON H; FRIESEN AD; WAINBERG MA; WRIGHT JA
      CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION

      Nucleosides & nucleotides
    36. ENJOLRAS N; GODINOT C
      INHIBITION OF UBIQUITOUS MITOCHONDRIAL CREATINE-KINASE EXPRESSION IN HELA-CELLS BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE

      Molecular and cellular biochemistry
    37. AGATSUMA T; ABE K; FURUKAWA H; KOGA R; KOIZUMI M; HOTODA H; KANEKO M
      PROTECTION OF HU-PBL-SCID BEIGE MICE FROM HIV-1 INFECTION BY A 6-MER MODIFIED OLIGONUCLEOTIDE, R-95288/

      Antiviral research
    38. NICOT A; OGAWA S; BERMAN Y; CARR KD; PFAFF DW
      EFFECTS OF AN INTRAHYPOTHALAMIC INJECTION OF ANTISENSE OLIGONUCLEOTIDES FOR PREPROENKEPHALIN MESSENGER-RNA IN FEMALE RATS - EVIDENCE FOR OPIOID INVOLVEMENT IN LORDOSIS REFLEX

      Brain research
    39. BOIZIAU C; TARRAGOLITVAK L; SINHA ND; MOREAU S; LITVAK S; TOULME JJ
      ANTISENSE OLIGONUCLEOTIDES INHIBIT IN-VITRO CDNA SYNTHESIS BY HIV-1 REVERSE-TRANSCRIPTASE

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    40. PERLAKY L; BUSCH RK; BUSCH H
      COMBINATORIAL EFFECTS OF MONOCLONAL ANTI-P120 ANTIBODY (MABP120), LIPOSOMES AND HYPERTHERMIA ON MCF-7 AND LOX TUMOR-CELL LINES

      Oncology research
    41. SAWAI K; MAHATO RI; OKA Y; TAKAKURA Y; HASHIDA M
      DISPOSITION OF OLIGONUCLEOTIDES IN ISOLATED-PERFUSED RAT-KIDNEY - INVOLVEMENT OF SCAVENGER RECEPTORS IN THEIR RENAL UPTAKE

      The Journal of pharmacology and experimental therapeutics
    42. DELBUFALO D; CUCCO C; LEONETTI C; CITRO G; DAGNANO I; BENASSI M; GEISER T; ZON G; CALABRETTA B; ZUPI G
      EFFECT OF CISPLATIN AND C-MYB ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES COMBINATION ON A HUMAN COLON-CARCINOMA CELL-LINE IN-VITRO AND IN-VIVO

      British Journal of Cancer
    43. LEDOAN T; ETORE F; MA DDF; TENU JP
      ANTISENSE OLIGONUCLEOTIDES - PERSPECTIVES FOR A MORE SELECTIVE CHEMOTHERAPY

      Annales de medecine interne
    44. DEMIRHAN I; HASSELMAYER O; HOFMANN D; CHANDRA A; SVINARCHUK FP; VLASSOV VV; ENGELS J; CHANDRA P
      GENE-TARGETED INHIBITION OF TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-LTR BY ANTISENSE OLIGONUCLEOTIDES

      Virus genes
    45. ZHANG RW; LU ZH; ZHAO H; ZHANG XS; DIASIO RB; HABUS I; JIANG ZW; IYER RP; YU D; AGRAWAL S
      IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS

      Biochemical pharmacology
    46. ZHANG RW; DIASIO RB; LU ZH; LIU TP; JIANG ZW; GALBRAITH WM; AGRAWAL S
      PHARMACOKINETICS AND TISSUE DISTRIBUTION IN RATS OF AN OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) DEVELOPED AS A THERAPEUTIC AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Biochemical pharmacology
    47. JACHIMCZAK P; BOGDAHN U; SCHNEIDER J; BEHL C; MEIXENSBERGER J; APFEL R; DORRIES R; SCHLINGENSIEPEN KH; BRYSCH W
      THE EFFECT OF TRANSFORMING GROWTH FACTOR-BETA(2)-SPECIFIC PHOSPHOROTHIOATE-ANTI-SENSE OLIGODEOXYNUCLEOTIDES IN REVERSING CELLULAR IMMUNOSUPPRESSION IN MALIGNANT GLIOMA

      Journal of neurosurgery


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 13:48:07